CPA CGMA - Proto Labs Controller Secretary
| PRLB Stock | USD 41.50 1.76 4.43% |
Executive
CPA CGMA is Controller Secretary of Proto Labs
| Address | 5540 Pioneer Creek Drive, Maple Plain, MN, United States, 55359 |
| Phone | 763 479 3680 |
| Web | https://www.protolabs.com |
Proto Labs Management Efficiency
The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0352 %, meaning that it created $0.0352 on every $100 dollars invested by stockholders. Proto Labs' management efficiency ratios could be used to measure how well Proto Labs manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to 0.03. In addition to that, Return On Capital Employed is expected to decline to 0.04. At present, Proto Labs' Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.41, whereas Total Assets are forecasted to decline to about 487.9 M.Similar Executives
| Found 12 records | EXECUTIVE Age | ||
| Rachel Roy | Evolv Technologies Holdings | N/A | |
| Parag Vaish | Evolv Technologies Holdings | N/A | |
| Joan JD | Dave Warrants | 64 | |
| Joan Aristei | Dave Warrants | 64 | |
| Liza Knapp | Evolv Technologies Holdings | N/A | |
| Brian Norris | Evolv Technologies Holdings | N/A | |
| Jay Muelhoefer | Evolv Technologies Holdings | 52 | |
| Courtney Cunnane | Evolv Technologies Holdings | N/A | |
| Kevin Frisch | Dave Warrants | N/A | |
| Alexandra Ozerkis | Evolv Technologies Holdings | N/A | |
| Eric Esq | Evolv Technologies Holdings | 67 | |
| Gopi Kuchimanchi | Dave Warrants | N/A | |
Management Performance
| Return On Equity | 0.0352 | ||||
| Return On Asset | 0.0242 |
Proto Labs Leadership Team
Elected by the shareholders, the Proto Labs' board of directors comprises two types of representatives: Proto Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Proto. The board's role is to monitor Proto Labs' management team and ensure that shareholders' interests are well served. Proto Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Proto Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oleg Ryaboy, Global Officer | ||
| Brian Peters, Chief Officer | ||
| Stacy Greiner, Director | ||
| Dan Schumacher, Interim Chief Financial Officer | ||
| Rainer Gawlick, Independent Director | ||
| Bram Zwart, Head Hubs | ||
| CPA CGMA, Controller Secretary | ||
| Robert Bodor, President, Chief Executive Officer, Interim Chief Technology Officer, Director | ||
| Sujeet Chand, Independent Director | ||
| Bjoern Klaas, Vice President, General Manager and Managing Director - Europe, Middle East and Africa | ||
| Victoria Holt, CEO and President and Director | ||
| Archie Black, Independent Chairman of the Board | ||
| Daniel Schumacher, Chief Officer | ||
| Sven Wehrwein, Independent Chairman of the Board | ||
| Alex Cappy, VP Hubs | ||
| Jason Frankman, Controller Secretary | ||
| John Way, Chief Financial Officer, Executive Vice President of Development | ||
| Arthur Baker, Chief Technology Officer | ||
| Moonhie Chin, Independent Director | ||
| Michael Kenison, VP Americas | ||
| Agnes Semington, Chief Officer | ||
| Donald Krantz, Executive VP and Technology Officer | ||
| John Goodman, Independent Director | ||
| Renee Conklin, VP HR |
Proto Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Proto Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0352 | ||||
| Return On Asset | 0.0242 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 920.76 M | ||||
| Shares Outstanding | 24.51 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 91.37 % | ||||
| Number Of Shares Shorted | 1.01 M | ||||
| Price To Earning | 27.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Proto Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Proto Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Proto Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Proto Labs Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Proto Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Proto Stock refer to our How to Trade Proto Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Proto Labs. If investors know Proto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Proto Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 0.94 | Revenue Per Share 19.816 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0242 |
The market value of Proto Labs is measured differently than its book value, which is the value of Proto that is recorded on the company's balance sheet. Investors also form their own opinion of Proto Labs' value that differs from its market value or its book value, called intrinsic value, which is Proto Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Proto Labs' market value can be influenced by many factors that don't directly affect Proto Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Proto Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Proto Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Proto Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.